| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/02/2004 | WO2004073657A2 Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases |
| 09/02/2004 | WO2004073604A2 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073603A2 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/02/2004 | WO2004058999A3 Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| 09/02/2004 | WO2004046691A3 Uncaging devices |
| 09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |
| 09/02/2004 | WO2004045371A3 Methods for diagnosing the presence or stage of cancer |
| 09/02/2004 | WO2004022702A3 Methods and reagents for identifying inhibitors of viral protease activity. |
| 09/02/2004 | WO2004015079A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/02/2004 | WO2004010101A3 Detection of chemical ligation using fluorescence quenching leaving groups |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003004689A3 Regulators of biofilm formation and uses thereof |
| 09/02/2004 | US20040172684 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 09/02/2004 | US20040171820 To be used in hybridization methods, for the determination of a nucleic acid |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171575 Antisense modulation of interferon gamma receptor 2 expression |
| 09/02/2004 | US20040171573 Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy |
| 09/02/2004 | US20040171571 5' CpG nucleic acids and methods of use |
| 09/02/2004 | US20040171570 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/02/2004 | US20040171565 vaccines that express derivatives of ADP-ribosyltransferase toxins that display significantly reduced, or are deficient in, intrinsic ADP-ribosyltransferase activity (i.e. herein referred to as mARTs) and yet retain adjuvanticity |
| 09/02/2004 | US20040171540 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 09/02/2004 | US20040171539 Regulation of human protein kinase-like protein |
| 09/02/2004 | US20040171150 Antisense nucleotide sequences for prevention and treatment of sepsis, viral infection, autoimmune and cell proliferative disorders |
| 09/02/2004 | US20040171108 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 09/02/2004 | US20040171057 Electro-optical devices and methods for hybridization and detection |
| 09/02/2004 | US20040171056 Using peptide nucleic acids to identify genic variations which enhance gene therapeutic and/or drug treatments |
| 09/02/2004 | US20040171054 Preparing biochips comprising multiple probes for use in genetic analysis; high throughput assay and medical diagnostics |
| 09/02/2004 | US20040171040 Detectable labeled nucleoside analogs and methods of use thereof |
| 09/02/2004 | US20040171033 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 09/02/2004 | US20040171032 Non-phosphorous-linked oligomeric compounds and their use in gene modulation |
| 09/02/2004 | US20040171031 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/02/2004 | US20040171030 Oligonucleotide sequences capable of binding RNA-induced silencing complexes for use in treatment and prevention of metabolic and cell proliferative disorders |
| 09/02/2004 | US20040171029 Comprises nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 09/02/2004 | US20040171028 Phosphorous-linked oligomeric compounds and their use in gene modulation |
| 09/02/2004 | US20040171015 Cyp450-specific dna probes and primers, and biological applications thereof |
| 09/02/2004 | US20040171007 Using oligonuclleotide and DNA amplification to identify mycobacterium in biological samples; clinical diagnostics |
| 09/02/2004 | US20040170992 Diagnostic polymorphisms of tgf-beta1 promoter |
| 09/02/2004 | US20040170980 Molecules capable of binding to telomere and the like and method with the use of the same |
| 09/02/2004 | US20040170974 for drug screening treatments for asthma/inflammatory disorders; genetic engineering; kits |
| 09/02/2004 | US20040170971 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 09/02/2004 | US20040170970 Split- ubiquitin based reporter systems and methods of their use |
| 09/02/2004 | US20040170951 Nucleotide sequences of the nucleocapsid (NP) and phosphoprotein (P) genes of a malaysian velogenic newcastle disease virus strain AF2240 and the production of the NP and P proteins in Escherichia coli |
| 09/02/2004 | US20040170641 Prevention and treatment of amyloidogenic disease |
| 09/02/2004 | CA2516013A1 Predicting graft rejection |
| 09/02/2004 | CA2515481A1 An expression cassette and vector for transient or stable expression of exogenous molecules |
| 09/02/2004 | CA2498650A1 Mycobacterial diagnostics |
| 09/01/2004 | EP1452598A1 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 09/01/2004 | EP1451374A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays |
| 09/01/2004 | EP1451365A2 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/01/2004 | EP1451364A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 09/01/2004 | EP1451351A2 Labelled nucleotides |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451325A2 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/01/2004 | EP1451320A2 Materials and methods for releasing genetic material |
| 09/01/2004 | EP1451318A1 Compilations of nucleic acids and arrays and methods of using them |
| 09/01/2004 | EP1451312A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
| 09/01/2004 | EP1451296A2 Expression of polypeptides in rod outer segment membranes |
| 09/01/2004 | EP1451291A2 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 09/01/2004 | EP1450857A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/01/2004 | EP1450821A1 Immunostimulatory oligodeoxynucleotides |
| 09/01/2004 | EP1244749B1 Mobility-modifying cyanine dyes |
| 09/01/2004 | EP1203094B1 Method for marking solid, liquid and gaseous substances |
| 09/01/2004 | EP1104487B1 Methods for exogenous, internal controls during nucleic acid amplification |
| 09/01/2004 | EP0937139B1 Amidase |
| 09/01/2004 | EP0728141B1 A method for identifying anti-parasitic compounds |
| 09/01/2004 | CN1526021A Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/01/2004 | CN1524958A Angiotensin II correlative gene, coding protein and application thereof |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164748C Wheat cyclin gene and its separating method and use |
| 09/01/2004 | CN1164616C Recombinant hepatitis B virus immune globulin |
| 09/01/2004 | CN1164607C Application of amination silicon shell type nanometer granular material in nucleic acid enriching and nanometer sensing process |
| 09/01/2004 | CN1164606C Gene of 26S proteinase alpha subunit for regulating degradation of mouseearcress abnormal protein |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6783972 Methods for large-scale production of recombinant AAV vectors |
| 08/31/2004 | US6783944 Genetic changes in atypical nodular proliferations in congenital melanocytic nevi |
| 08/31/2004 | US6783942 Isolated polynucleotide associated with type II diabetes mellitus and methods of use thereof |
| 08/31/2004 | US6783934 Useful for diagnosis, monitoring changing levels of viral nucleic acid in a patient throughout course of illness (hiv) |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/31/2004 | US6783759 Compositions and methods for modulating variola virus |
| 08/26/2004 | WO2004072297A2 Terminal-phosphate-labeled nucleotides and methods of use |
| 08/26/2004 | WO2004072293A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 08/26/2004 | WO2004072269A2 Bex4 nucleic acids, polypeptides, and method of using |
| 08/26/2004 | WO2004072259A2 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof |
| 08/26/2004 | WO2004072256A2 Variants of cytochrome c and methods of diagnostics of thrombocytopenia |
| 08/26/2004 | WO2004072253A2 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 08/26/2004 | WO2004072252A2 Polymerase-based protocols for the introduction of deletions and insertions |
| 08/26/2004 | WO2004072247A2 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides |
| 08/26/2004 | WO2004072246A2 Polymerase-based protocols for the introduction of combinatorial deletions and insertions |
| 08/26/2004 | WO2004072245A2 Polymerase-based protocols for the introductions of deletions and insertions |
| 08/26/2004 | WO2004072244A2 Polymerase-based protocols for generating chimeric oligonucleotides |
| 08/26/2004 | WO2004072237A2 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine |
| 08/26/2004 | WO2004072233A2 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use |
| 08/26/2004 | WO2004072229A2 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | WO2004072110A1 Methods for inhibiting signal transduction |
| 08/26/2004 | WO2004072096A2 Peptides binding gp120 of hiv-1 |
| 08/26/2004 | WO2004071468A2 Short immunomodulatory oligonucleotides |
| 08/26/2004 | WO2004071462A2 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 08/26/2004 | WO2004071430A2 RNAi TARGETING OF VIRUSES |